Answer
Jul 31, 2025 - 09:44 AM
Elvitegravir, cobicistat, emtricitabine, and tenofovir are combined in a single tablet used as an antiretroviral medication for the treatment of HIV-1 infection. Elvitegravir is an integrase inhibitor that prevents viral replication, while cobicistat acts as a pharmacokinetic enhancer to increase elvitegravir levels. Emtricitabine and tenofovir are nucleoside reverse transcriptase inhibitors (NRTIs) that help block the virus's ability to replicate. Together, they work to reduce the viral load in the body and help maintain a suppressed viral state.
